INJECTION SITE ERYTHEMA

This adverse event was reported 119407 times

These drugs are most commonly taken by patients reporting INJECTION SITE ERYTHEMA:

# Drug Count
0 ETANERCEPT 41026
1 ADALIMUMAB 15205
2 DUPILUMAB 10065
3 METHOTREXATE SODIUM 6337
4 METHOTREXATE 6237
5 TERIPARATIDE 5052
6 TIRZEPATIDE 4771
7 INTERFERON BETA-1A 3782
8 PREDNISONE 3021
9 ERGOCALCIFEROL 2836
See all common drugs associated with INJECTION SITE ERYTHEMA

INJECTION SITE ERYTHEMA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 NAPROXEN SODIUM, PSEUDOEPHEDRINE HYDROCHLORIDE 67 4.7857
1 BETAMETHASONE SODIUM PHOSPHATE AND BETAMETHASONE ACETATE 13 0.3250
2 RILONACEPT 115 0.1197
3 OCRELIZUMAB AND HYALURONIDASE 34 0.1133
4 TUBERCULIN PURIFIED PROTEIN DERIVATIVE 241 0.0941
5 PEGVALIASE-PQPZ 721 0.0910
6 OLEZARSEN SODIUM 37 0.0905
7 ASFOTASE ALFA 844 0.0896
8 LENACAPAVIR SODIUM 37 0.0894
9 GLATIRAMER ACETATE INJECTION 387 0.0846
See all drugs enriched for association with INJECTION SITE ERYTHEMA